Bayer Pharmaceuticals, the manufacturers of the erectile dysfunction medication Levitra, have submitted an application to have a new formulation of the drug registered in the European Union.
Bayer are excited about the new formula, which they hope will improve the currently flagging sales of the medicine. They plan to sell the medicine in the form on an orodispersible tablet containing 10mg of vardenafil, the medical name for Levitra. The pill will dissolves on the tongue in seconds. This would give Levitra an edge of the competition, as both Cialis and Viagra need to be taken with water.
They hope that the new type of pill will prove more discreet and convenient, as men will not need to interrupt foreplay to get a glass of water to take their medication with.
A representative from Bayer, Jean-Philippe Milon, said that the new formula marked a ‘strategic milestone’ in the development of ‘innovative and easy-to-use men’s health products’.
The pharmaceutical company have completed two large phase III clinical studies which they say showed the the new formulation is as safe and effective as the current pills on the market.